Abstract
Granulomatous lesions of the orofacial region are a heterogeneous group of disorders characterized by a granulomatous reaction to a variety of stimuli. Infectious agents, foreign material, systemic inflammation and metabolic disorders can all be associated with granulomatous inflammation. In the orofacial region primary causes of granulomatosis include foreign body reaction, delayed hypersensitivity to topical agents and idiopathic orofacial granulomatosis. Secondary causes of granulomas include infectious agents, sarcoid, and Crohn disease. For this review, infectious causes of orofacial granulomatosis (OFG) including bacteria, parasites and fungi will not be discussed.
Similar content being viewed by others
References
Al-Hamad A, Porter S, Fedele S. Orofacial granulomatosis. Dermatol Clin. 2015;33(3):433–46.
Troiano G, Dioguardi M, Giannatempo G, et al. Orofacial granulomatosis: clinical signs of different pathologies. Med Princ Pract. 2015;24(2):117–22.
Miest R, Bruce A, Rogers RS. Orofacial granulomatosis. Clin Dermatol. 2016;34(4):505–13.
Grave B, McCullough M, Wiesenfeld D. Orofacial granulomatosis—a 20-year review. Oral Dis. 2009;15(1):46–51.
Ito T, Connett JM, Kunkel SL, Matsukawa A. The linkage of innate and adaptive immune response during granulomatous development. Front Immunol. 2013;31:4–10.
Terziroli Beretta-Piccoli B, Mainetti C, Peeters MA, Laffitte E. Cutaneous granulomatosis: a comprehensive review. Clin Rev Allergy Immunol. 2018;54(1):131–46.
Shah KK, Pritt BS, Alexander MP. Histopathologic review of granulomatous inflammation. J Clin Tuberc Other Mycobact Dis. 2017;7:1–12.
Wick MR. Granulomatous & histiocytic dermatitides. Semin Diagn Pathol. 2017;34(3):301–311.
Fitzpatrick L, Healy CM, McCartan BE, et al. Patch testing for food-associated allergies in orofacial granulomatosis. J Oral Pathol Med. 2011;40(1):10–3.
Miest RY, Bruce AJ, Comfere NI, et al. A diagnostic approach to recurrent orofacial swelling: a retrospective study of 104 patients. Mayo Clin Proc. 2017;92(7):1053–1060.
Mignogna MD, Fedele S, Lo Russo L, Lo Muzio L. The multiform and variable patterns of onset of orofacial granulomatosis. J Oral Pathol Med. 2003;32(4):200–5.
Gale G, Sigurdsson GV, Östman S, et al. Does Crohn’s disease with concomitant orofacial granulomatosis represent a distinctive disease subtype? Inflamm Bowel Dis. 2016;22(5):1071–7.
Marcoval J, Penín RM. Histopathological features of orofacial granulomatosis. Am J Dermatopathol. 2016;38(3):194–200.
Wiesenfeld D, Ferguson MM, Mitchell DN, et al. Oro-facial granulomatosis—a clinical and pathological analysis. Q J Med. 1985;54(213):101–13.
Melkersson E. Ett fall av recidiverande facialispares i samband med ett angioneurotiskt dem. Vol. 90. Stockholm: Hygiea; 1928. pp. 737e41.
Critchlow WA, Chang D. Cheilitis granulomatosa: a review. Head Neck Pathol. 2014;8(2):209–13.
Rogers RS. Granulomatous cheilitis, Melkersson–Rosenthal syndrome, and orofacial granulomatosis. Arch Dermatol. 2000;136(12):1557–8. rd .
Al Johani K, Moles DR, Hodgson T, Porter SR, Fedele S. Onset and progression of clinical manifestations of orofacial granulomatosis. Oral Dis. 2009;15(3):214–9.
Cocuroccia B, Gubinelli E, Annessi G, Zambruno G, Girolomoni G. Persistent unilateral orbital and eyelid oedema as a manifestation of Melkersson–Rosenthal syndrome. J Eur Acad Dermatol Venereol. 2005;19(1):107–11.
Rivera-Serrano CM, Man LX, Klein S, Schaitkin BM. Melkersson–Rosenthal syndrome: a facial nerve center perspective. J Plast Reconstr Aesthet Surg. 2014;67(8):1050–4.
Kanerva M, Moilanen K, Virolainen S, Vaheri A, Pitkäranta A. Melkersson–Rosenthal syndrome. Otolaryngol Head Neck Surg. 2008;138(2):246–51.
Lazzerini M, Martelossi S, Cont G, et al. Orofacial granulomatosis in children: think about Crohn’s disease. Dig Liver Dis. 2015;47(4):338–41.
Lazzerini M, Bramuzzo M, Ventura A. Association between orofacial granulomatosis and Crohn’s disease in children: systematic review. World J Gastroenterol. 2014;20(23):7497–504.
Bharti R, Wadhwani KK, Tikku AP, Chandra A. Dental amalgam: an update. J Conserv Dent. 2010;13(4):204–8.
Telang LA. Body art: intraoral tattoos. Br Dent J. 2015;218(4):212–3.
Haneke E. Adverse effects of fillers. Dermatol Ther. 2018;5:e12676. https://doi.org/10.1111/dth.12676.
Requena L, Requena C, Christensen L, et al. Adverse reactions to injectable soft tissue fillers. J Am Acad Dermatol. 2011;64(1):1–34. quiz 35–6.
Eversole R, Tran K, Hansen D, Campbell J. Lip augmentation dermal filler reactions, histopathologic features. Head Neck Pathol. 2013;7(3):241–9.
Shahrabi-Farahani S, Lerman MA, Noonan V, Kabani S, Woo SB. Granulomatous foreign body reaction to dermal cosmetic fillers with intraoral migration. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117(1):105–10.
Requena C, Requena L, Alegre V, et al. Adverse reaction to silicone simulating orofacial granulomatosis. J Eur Acad Dermatol Venereol. 2015;29(5):998–1001.
Feuerstein JD, Cheifetz AS. Crohn disease: epidemiology, diagnosis, and management. Mayo Clin Proc. 2017;92(7):1088–1103.
Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46–54.e42.
Gajendran M, Loganathan P, Catinella AP, Hashash JG. A comprehensive review and update on Crohn’s disease. Dis Mon. 2018;64(2):20–57.
Eckel A, Lee D, Deutsch G, Maxin A, Oda D. Oral manifestations as the first presenting sign of Crohn’s disease in a pediatric patient. J Clin Exp Dent. 2017;9(7):e934–8.
Woo VL. Oral manifestations of Crohn’s disease: a case report and review of the literature. Case Rep Dent. 2015;2015:830472.
Sanderson J, Nunes C, Escudier M, et al. Oro-facial granulomatosis: Crohn’s disease or a new inflammatory bowel disease? Inflamm Bowel Dis. 2005;11(9):840–6.
Hoekman DR, Diederen K, Benninga MA. Crohn’s disease with orofacial granulomatosis is a distinct disease subtype, or is it? Inflamm Bowel Dis. 2016;22(7):E23.
Gale G, Östman S, Rekabdar E, et al. Characterisation of a Swedish cohort with orofacial granulomatosis with or without Crohn’s disease. Oral Dis. 2015;21(1):e98–104.
Campbell H, Escudier M, Patel P, et al. Distinguishing orofacial granulomatosis from crohn’s disease: two separate disease entities? Inflamm Bowel Dis. 2011;17(10):2109–15.
Haaramo A, Alapulli H, Aine L, et al. Detailed Follow-up Study of Pediatric Orofacial Granulomatosis Patients. J Pediatr Gastroenterol Nutr. 2017;65(4):388–93.
Arkema EV, Cozier YC. Epidemiology of sarcoidosis: current findings and future directions. Ther Adv Chronic Dis. 2018;9(11):227–240.
Nico MM, Guimarães AL, Correa PY, Lourenço SV. Oral mucosal lesions in sarcoidosis: comparison with cutaneous lesions. Acta Derm Venereol. 2016;96(3):392–3.
James WE, Koutroumpakis E, Saha B, et al. Clinical features of extrapulmonary sarcoidosis without lung involvement. Chest. 2018;154(2):349–56.
Bouaziz A, Le Scanff J, Chapelon-Abric C, et al. Oral involvement in sarcoidosis: report of 12 cases. QJM. 2012;105(8):755–67.
Bargagli E, Prasse A. Sarcoidosis: a review for the internist. Intern Emerg Med. 2018;13(3):325–31.
Wessendorf TE, Bonella F, Costabel U. Diagnosis of sarcoidosis. Clin Rev Allergy Immunol. 2015;49(1):54–62.
Funding
No funding was required for this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author declares they have no conflicts of interest.
Ethical Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Rights and permissions
About this article
Cite this article
Müller, S. Non-infectious Granulomatous Lesions of the Orofacial Region. Head and Neck Pathol 13, 449–456 (2019). https://doi.org/10.1007/s12105-018-00997-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12105-018-00997-w